Benralizumab can be used for the treatment of acute eosinophilic exacerbations of asthma and chronic obstructive pulmonary ...

Using just one inhalation lung CT scan, a deep learning model can accurately diagnose and stage chronic obstructive pulmonary ...

US FDA accepts GSK’s submission for the use of Nucala to treat patients with chronic obstructive pulmonary disease: London, UK Wednesday, December 11, 2024, 10:00 Hrs [IST] GSK ...

Cardiopulmonary assessment tool detects and monitors digital biomarkers to support health management and help improve ...

Residents of Timișoara, in western Romania, can undergo free spirometry tests in a special tram as part of the ...

According to the World Health Organization (WHO), chronic obstructive pulmonary disease (COPD) is the third leading cause of ...

While smoking remains the leading risk factor for COPD, non-smokers should be aware of other environmental and occupational ...

Mepolizumab, a biologic approved for asthma, is not currently approved for COPD, but data from a 2017 study showed a trend ...

Obesity has this year overtaken smoking as Australia's leading risk factor contributing to disease, according to a national ...

November is National Chronic Obstructive Pulmonary Disease Awareness Month. It’s time to raise awareness about lung disease within our communities. By understanding the causes, reducing our risk ...

A British family is raising money for their grandmother after she fell ill while on holiday, after she travelled without ...

The FDA has accepted for review the BLA for mepolizumab as an add-on maintenance treatment for eosinophilic COPD.